These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6650517

  • 21. Quality control in admixture services.
    Zellmer WA.
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract] [Full Text] [Related]

  • 22. Society of Hospital Pharmacists of Australia: are you at risk?
    Aust Hosp; 1981 Jul; (54):4-5. PubMed ID: 10254354
    [No Abstract] [Full Text] [Related]

  • 23. Statement on the competencies required in institutional pharmacy practice.
    Am J Hosp Pharm; 1975 Sep; 32(9):917-9. PubMed ID: 1190250
    [No Abstract] [Full Text] [Related]

  • 24. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract] [Full Text] [Related]

  • 25. Ethics of automated compounding and dispensing.
    Buchanan EC.
    Pharm Pract Manag Q; 1995 Oct; 15(3):66-71. PubMed ID: 10151714
    [No Abstract] [Full Text] [Related]

  • 26. ASHP Guidelines on Outsourcing Sterile Compounding Services.
    Am J Health Syst Pharm; 2015 Oct 01; 72(19):1664-75. PubMed ID: 26386108
    [No Abstract] [Full Text] [Related]

  • 27. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO, Gyllenspetz L, Hartvig P, Levol R, Rane A, Söderström A.
    Lakartidningen; 1996 Oct 30; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract] [Full Text] [Related]

  • 28. Safety in the preparation of cytotoxic drugs: How to integrate gravimetric control in the quality assurance policy?
    Lecordier J, Heluin Y, Plivard C, Bureau A, Mouawad C, Chaillot B, Lahet JJ.
    Biomed Pharmacother; 2011 Feb 30; 65(1):17-21. PubMed ID: 21276695
    [Abstract] [Full Text] [Related]

  • 29. Quality assurance for pharmacy-prepared sterile products in hospitals and home infusion facilities.
    Klein C.
    Am J Health Syst Pharm; 1996 Nov 01; 53(21):2581. PubMed ID: 8913385
    [No Abstract] [Full Text] [Related]

  • 30. Perspective on sterile compounding practices and the draft guidelines.
    Tormo VJ.
    Am J Hosp Pharm; 1992 Apr 01; 49(4):946-7. PubMed ID: 1595725
    [No Abstract] [Full Text] [Related]

  • 31. Expiry date guidelines for a centralized IV admixture service.
    Stroup JW, Mighton-Eryou LM.
    Can J Hosp Pharm; 1986 Jun 01; 39(3):57-9, 66. PubMed ID: 10311616
    [Abstract] [Full Text] [Related]

  • 32. [Prevention of preparation errors of cytotoxic drugs in centralized units: from epidemiology to quality assurance].
    Martin F, Legat C, Coutet J, Bracco-Nolin CH, Jacquet M, Woronoff-Lemsi MC, Limat S.
    Bull Cancer; 2004 Dec 01; 91(12):972-6. PubMed ID: 15634638
    [Abstract] [Full Text] [Related]

  • 33. [The use of drugs: current situation and future prospects].
    Berti T, Benoni G, Minelli EB, Fracasso ME, Velo G.
    Clin Ter; 1977 Dec 31; 83(6):569-82. PubMed ID: 608310
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Design and implementation of a quality-assurance program for pharmaceutical services.
    Horowitz KN, Lamnin M.
    Am J Hosp Pharm; 1980 Jan 31; 37(1):82-4. PubMed ID: 7361777
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.